Zdrowie i gospodarka · 13/05/2015
FDA Releases Revised Draft Guidance on Biosimilars Implementation
The FDA has released a revised draft guidance for industry on biosimilars, addressing common questions from sponsors and BLA holders regarding the Biologics Price Competition and Innovation Act of 2009.
Source: Federal Register — Food and Drug AdministrationOpen original release →